R01-CA166907/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2011	1
2014	3
2015	1
2016	1
2017	3
2018	2
2019	5
2021	1
2024	0

1

Mechanisms of Cisplatin-Induced Ototoxicity and Prevention.

Rybak LP, Mukherjea D, Ramkumar V. Rybak LP, et al. Semin Hear. 2019 May;40(2):197-204. doi: 10.1055/s-0039-1684048. Epub 2019 Apr 26. Semin Hear. 2019. PMID: 31036996 Free PMC article. Review.

2

Adenosine receptors: expression, function and regulation.

Sheth S, Brito R, Mukherjea D, Rybak LP, Ramkumar V. Sheth S, et al. Int J Mol Sci. 2014 Jan 28;15(2):2024-52. doi: 10.3390/ijms15022024. Int J Mol Sci. 2014. PMID: 24477263 Free PMC article. Review.

3

Mechanisms of Cisplatin-Induced Ototoxicity and Otoprotection.

Sheth S, Mukherjea D, Rybak LP, Ramkumar V. Sheth S, et al. Front Cell Neurosci. 2017 Oct 27;11:338. doi: 10.3389/fncel.2017.00338. eCollection 2017. Front Cell Neurosci. 2017. PMID: 29163050 Free PMC article. Review.

4

Early investigational drugs for hearing loss.

Mukherjea D, Ghosh S, Bhatta P, Sheth S, Tupal S, Borse V, Brozoski T, Sheehan KE, Rybak LP, Ramkumar V. Mukherjea D, et al. Expert Opin Investig Drugs. 2015 Feb;24(2):201-17. doi: 10.1517/13543784.2015.960076. Epub 2014 Sep 22. Expert Opin Investig Drugs. 2015. PMID: 25243609 Free PMC article. Review.

5

Local Drug Delivery for Prevention of Hearing Loss.

Rybak LP, Dhukhwa A, Mukherjea D, Ramkumar V. Rybak LP, et al. Front Cell Neurosci. 2019 Jul 9;13:300. doi: 10.3389/fncel.2019.00300. eCollection 2019. Front Cell Neurosci. 2019. PMID: 31338024 Free PMC article. Review.

6

Targeting Inflammatory Processes Mediated by TRPVI and TNF-α for Treating Noise-Induced Hearing Loss.

Dhukhwa A, Bhatta P, Sheth S, Korrapati K, Tieu C, Mamillapalli C, Ramkumar V, Mukherjea D. Dhukhwa A, et al. Front Cell Neurosci. 2019 Oct 3;13:444. doi: 10.3389/fncel.2019.00444. eCollection 2019. Front Cell Neurosci. 2019. PMID: 31632242 Free PMC article.

7

Epigallocatechin-3-gallate, a prototypic chemopreventative agent for protection against cisplatin-based ototoxicity.

Borse V, Al Aameri RFH, Sheehan K, Sheth S, Kaur T, Mukherjea D, Tupal S, Lowy M, Ghosh S, Dhukhwa A, Bhatta P, Rybak LP, Ramkumar V. Borse V, et al. Cell Death Dis. 2017 Jul 13;8(7):e2921. doi: 10.1038/cddis.2017.314. Cell Death Dis. 2017. PMID: 28703809 Free PMC article.

8

The Endocannabinoid/Cannabinoid Receptor 2 System Protects Against Cisplatin-Induced Hearing Loss.

Ghosh S, Sheth S, Sheehan K, Mukherjea D, Dhukhwa A, Borse V, Rybak LP, Ramkumar V. Ghosh S, et al. Front Cell Neurosci. 2018 Aug 21;12:271. doi: 10.3389/fncel.2018.00271. eCollection 2018. Front Cell Neurosci. 2018. PMID: 30186120 Free PMC article.

9

TRPV1: A Potential Drug Target for Treating Various Diseases.

Brito R, Sheth S, Mukherjea D, Rybak LP, Ramkumar V. Brito R, et al. Cells. 2014 May 23;3(2):517-45. doi: 10.3390/cells3020517. Cells. 2014. PMID: 24861977 Free PMC article.

10

Adenosine A1 Receptor Protects Against Cisplatin Ototoxicity by Suppressing the NOX3/STAT1 Inflammatory Pathway in the Cochlea.

Kaur T, Borse V, Sheth S, Sheehan K, Ghosh S, Tupal S, Jajoo S, Mukherjea D, Rybak LP, Ramkumar V. Kaur T, et al. J Neurosci. 2016 Apr 6;36(14):3962-77. doi: 10.1523/JNEUROSCI.3111-15.2016. J Neurosci. 2016. PMID: 27053204 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

16 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year